| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 195 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 182 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 148 | 2024 |
| The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis B Sartorius, AP Gray, ND Weaver, GR Aguilar, LR Swetschinski, KS Ikuta, ... The Lancet Global Health 12 (2), e201-e216, 2024 | 52 | 2024 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 46 | 2024 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 31 | 2023 |
| The practicality of the use of liquid biopsy in early diagnosis and treatment monitoring of oral cancer in resource-limited settings HA Adeola, IO Bello, RT Aruleba, NM Francisco, TA Adekiya, AO Adefuye, ... Cancers 14 (5), 1139, 2022 | 26 | 2022 |
| Incidence of Hodgkin lymphoma in HIV-positive and HIV-negative patients at a tertiary hospital in South Africa (2005-2016) and comparison with other African countries N Naidoo, F Musaigwa South African Medical Journal 108 (7), 2018 | 23 | 2018 |
| Type 2 immunity: a two-edged sword in schistosomiasis immunopathology NA Aziz, F Musaigwa, P Mosala, I Berkiks, F Brombacher Trends in Immunology 43 (8), 657-673, 2022 | 22 | 2022 |
| Schistosoma mansoni infection induces plasmablast and plasma cell death in the bone marrow and accelerates the decline of host vaccine responses F Musaigwa, SD Kamdem, T Mpotje, P Mosala, N Abdel Aziz, ... PLoS Pathogens 18 (2), e1010327, 2022 | 21 | 2022 |
| Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 JR Ledesma, J Ma, M Zhang, AVL Basting, HT Chu, A Vongpradith, ... The Lancet Infectious Diseases, 2024 | 20 | 2024 |
| Influence of schistosomiasis on host vaccine responses JK Nono, SD Kamdem, F Musaigwa, CA Nnaji, F Brombacher Trends in Parasitology 38 (1), 67-79, 2022 | 19 | 2022 |
| Immunoinformatics studies and design of a potential multi-epitope peptide vaccine to combat the fatal visceral leishmaniasis OS Onile, F Musaigwa, N Ayawei, V Omoboyede, TA Onile, ... Vaccines 10 (10), 1598, 2022 | 8 | 2022 |
| Praziquantel treatment of Schistosoma mansoni infected mice renders them less susceptible to reinfection JK Nono, T Mpotje, P Mosala, NA Aziz, F Musaigwa, L Hlaka, ... Frontiers in Immunology 12, 748387, 2021 | 7 | 2021 |
| In-depth investigation of turn-around time of full blood count tests requested from a clinical haematology outpatient department in Cape Town, South Africa L Mutema, Z Chapanduka, F Musaigwa, N Mashigo African journal of laboratory medicine 10 (1), 1-6, 2021 | 3 | 2021 |
| Harnessing Schistosoma-associated metabolite changes in the human host to identify biomarkers of infection and morbidity: Where are we and what should we do … M Kameni, F Musaigwa, LM Kamguia, SD Kamdem, G Mbanya, ... PLOS Neglected Tropical Diseases 18 (3), e0012009, 2024 | 2 | 2024 |
| Chronic lymphocytic leukaemia trends and features at a tertiary hospital in South Africa (2011–2016) F Musaigwa, R Grewal, A Abayomi, CC Swanepoel South African Journal of Oncology 5, 168, 2021 | 2 | 2021 |
| MrgprA3 neurons drive cutaneous immunity against helminths through selective control of myeloid-derived IL-33 JM Inclan-Rico, CM Napuri, C Lin, LY Hung, AA Ferguson, X Liu, Q Wu, ... Nature Immunology, 1-17, 2024 | | 2024 |
| Cysteinyl leukotriene receptor-1 as a potential target for host-directed therapy during chronic schistosomiasis in murine model P Mosala, T Mpotje, N Abdel Aziz, H Ndlovu, F Musaigwa, JK Nono, ... Frontiers in Immunology 15, 1279043, 2024 | | 2024 |
| Supplementary appendix 1: methods appendix to" Global fertility in 204 countries and territories, 1950-2021 with forecasts to 2100: a comprehensive demographic analysis for the … N Bhattacharjee, A Schumacher, A Aali, Y Habtegiorgis, S Muthu, ... The Lancet, 2024 | | 2024 |
